Quantitative analysis further demonstrated a significant increase in the proportion of GMPs ( p < 0.05) and a decreasing trend in CLPs in MS patients compared to controls (Figure 1F ).
← all excerpts
Innate Immune Reprogramming Mediated by Endogenous Retroelement Dysregulation Drives Multiple Sclerosis Progression.
1
—
—